Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date

E-ISSN： 2210-3104|4|2|119-127

ISSN： 2210-3090

Source： Recent Patents on Biomarkers, Vol.4, Iss.2, 2014-05, pp. : 119-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers in Molecularly Targeted Therapy for Cancer

Recent Patents on Biomarkers, Vol. 1, Iss. 2, 2011-05 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF and HIF in Renal Cell Carcinogenesis

Recent Patents on Biomarkers, Vol. 1, Iss. 1, 2011-01 ,pp. : 60-67

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Wall-Related Biomarkers in Sepsis: A Review of Current Evidence and a Critical Appraisal of Recent Patents

Recent Patents on Biomarkers, Vol. 2, Iss. 2, 2012-05 ,pp. : 113-118

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Angiogenesis: A Target for Renal Cell Carcinoma Therapy. Current Perspectives and Novel Strategies

Recent Patents on Biomarkers, Vol. 2, Iss. 2, 2012-01 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Experimental intravenous cell therapy of acute and chronic renal failure

By Kirpatovskii V. Kazachenko A. Plotnikov E. Marei M. Musina R. Nadtochii O. Kon’kova T. Drozhzheva V. Sukhikh G.

Bulletin of Experimental Biology and Medicine, Vol. 143, Iss. 1, 2007-01 ,pp. : 160-165

Springer Publishing Company

Access to resources Recommend Favorite